Loading…
← CockpitCompetitor Analysis › 002876.SZ Shenzhen Sunnypol Optoelectornics Co. Ltd. Class AOpen in the cockpit ↗

Shenzhen Sunnypol Optoelectornics Co. Ltd. Class A002876.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties
Momentum leader 84
Mkt cap
$680M
US dollars, full cap
Free float
73%
of shares outstanding
$/day
$31.5M
20-day average traded
Fwd P/E
39.0×
forward earnings
ROIC−WACC
-2.3 pp
WACC 8.7%
Hurdle
-4 pp
Req g minus delivered
Next earnings
114 days
12 Mar 2027
Close · CNYCN¥27.05
1D-3.4%
1W-13.5%
1M-5.7%
3M-0.9%
6M-8.9%
YTD+13.0%
1Y+14.3%
ATR %6.6%
52w lowhigh23.9% off high

What Shenzhen Sunnypol Optoelectornics does

Employees: 3,611

Shenzhen Sunnypol Optoelectornics at a glance

Size Shenzhen Sunnypol Optoelectornics (002876.SZ) is a China Health Care company (Medical Specialties) with a market value of $680M, the 2953rd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥27.05 on 18 Nov 2026.

Performance Over six months the shares fell 8.9%, against -15.1% for the median peer and -20.0% for the China market (cap-weighted) — 8th highest of 21 in its peer set.

Growth Revenue grew 29.4% over the last twelve months (peer median +15.8%); the operating margin is 4.6% (peer median 17.0%).

Valuation It trades at 39.0× forward earnings against a peer median of 20.7× (4th most expensive of 17).

Price implies For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -4 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.3 points below its cost of capital (8.7% WACC).

Next results Next results expected around 12 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026002876.SZ 91Peer median 86
Six months, rebased to 100: Shenzhen Sunnypol Optoelectornics against the median of its 20 peers (local-currency closes).

Shenzhen Sunnypol Optoelectornics financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥4.35BCN¥3.68BCN¥2.58BCN¥2.06BCN¥2.17B
Revenue growth—+43%+25%-5%—
Gross profitCN¥922MCN¥540MCN¥418MCN¥283MCN¥450M
EBITDAn/aCN¥376MCN¥261MCN¥165MCN¥344M
Net incomeCN¥122MCN¥47.1MCN¥68.1MCN¥42.8MCN¥206M
Free cash flowCN¥346M-CN¥157M-CN¥438M-CN¥630MCN¥164M
Capital expenditureCN¥144MCN¥350MCN¥481MCN¥679MCN¥252M
Total debtCN¥2.58BCN¥2.59BCN¥1.82BCN¥1.24BCN¥965M

Quarterly statements and history in the cockpit →

Shenzhen Sunnypol Optoelectornics competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%DCTH491000688389688085301234300326SNT15017575QDEL688410300622178930112218584728688179301367600855INMD002876.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Shenzhen Sunnypol Optoelectornics is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%0×200×DCTH688389688085300326SNT15017575QDEL30062217893011221858002876.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shenzhen Sunnypol Optoelectornics is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%DCTH688389688085301234300326SNT1501757568841017894728688179002876.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Shenzhen Sunnypol Optoelectornics is the large dot.

Shenzhen Sunnypol Optoelectornics competitors and peer comparison

How Shenzhen Sunnypol Optoelectornics compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shenzhen Sunnypol Optoelectornics against its 20 peers (data as of 18 Nov 2026)
Measure002876.SZPeer medianRank in peer set
1-month return-5.7%-6.6%11th highest of 21
6-month return-8.9%-15.1%8th highest of 21
Distance from 52-week high-23.9%-35.5%8th highest of 21
Revenue growth (TTM)+29.4%+15.8%9th highest of 21
Operating margin4.6%17.0%7th lowest of 21
Forward P/E39.0×20.7×4th most expensive of 17
Growth the price implies (Req g, 7 yrs)10.1%-0.6%7th most demanding of 17
Growth delivered (Del g)+14.2%+14.5%9th highest of 17
Hurdle (Req g minus delivered)-4.0 pp-14.7 pp5th most demanding of 17
ROIC minus cost of capital-2.3 pp+5.1 pp6th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Shenzhen Sunnypol Optoelectornics 002876.SZChina$680M-9%+29%5%39.0×10.1%+14.2%
Delcath Systems DCTHUnited States$685M+75%+38%5%358.9×33.4%+120.2%
Livsmed 491000.KSSouth Korea$687M-47%+89%-77%n/an/an/a
Shenzhen Lifotronic Technology 688389.SSChina$692M-14%+14%13%29.9×11.6%+13.3%
Shanghai Sanyou Medical 688085.SSChina$692M-23%+15%4%50.0×29.0%+6.8%
Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZChina$697M+148%-14%3%n/a31.8%-0.6%
Shanghai Kinetic Medical 300326.SZChina$662M-10%-28%17%26.0×6.6%-1.9%
Synektik SNT.WAPoland$662M+10%+32%24%13.8×0.2%+47.5%
Shanghai INT Medical Instruments 1501.HKHong Kong$700M-25%+35%21%15.9×-3.3%+23.5%
Japan Lifeline 7575.TJapan$703M+34%+6%19%14.5×-9.5%+2.9%
QuidelOrtho QDELUnited States$657M-20%-5%-2%10.7×n/an/a
SWS Hemodialysis Care 688410.SSChina$706M-11%+31%19%23.5×16.2%+25.9%
Doctorglasses Chain 300622.SZChina$710M-22%+6%14%22.8×-3.4%+15.7%
AK Medical 1789.HKHong Kong$642M-23%+16%26%10.5×-11.5%+6.7%
Caina Technology 301122.SZChina$721M+36%+61%0%55.4×n/an/a
Beijing Chunlizhengda Medical Instruments 1858.HKHong Kong$631M-28%-9%31%8.5×-9.5%+1.5%
SunMax Biotechnology 4728.TWOTaiwan$630M0%+19%51%n/a-2.6%+18.8%
Shanghai Aladdin Biochemical Technology 688179.SSChina$736M-37%+39%24%27.4×17.1%+24.2%
BMC Medical 301367.SZChina$737M-17%+37%17%18.7×-1.5%+15.6%
Beijing Aerospace Changfeng 600855.SSChina$738M-44%-10%-19%n/an/an/a
InMode INMDUnited States$741M-8%+2%18%9.8×-10.8%+12.4%

Questions

Which companies are Shenzhen Sunnypol Optoelectornics's closest peers?
The cockpit's peer set: Delcath Systems (DCTH), Livsmed (491000.KS), Shenzhen Lifotronic Technology (688389.SS), Shanghai Sanyou Medical (688085.SS), Anhui Hongyu Wuzhou Medical Manufacturer (301234.SZ), Shanghai Kinetic Medical (300326.SZ), Synektik (SNT.WA), Shanghai INT Medical Instruments (1501.HK).
Is Shenzhen Sunnypol Optoelectornics expensive compared with its peers?
On forward p/e it trades at 39.0× against a peer median of 20.7×, 4th most expensive of 17 in its peer set. For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -4 pp: the price already allows for a slowdown.
How has Shenzhen Sunnypol Optoelectornics stock performed?
Over six months to 18 Nov 2026 the shares returned -8.9% against -15.1% for the median peer; over one year +14.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.